RA Capital Management - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$19,387,306
-58.8%
1,131,775
-53.0%
0.44%
-54.0%
Q4 2022$47,107,906
+40.1%
2,407,149
+14.2%
0.96%
+33.2%
Q3 2022$33,630,000
+16.0%
2,107,1490.0%0.72%
-7.2%
Q2 2022$28,994,000
-13.2%
2,107,1490.0%0.77%
+6.0%
Q1 2022$33,419,000
-27.3%
2,107,1490.0%0.73%
-10.1%
Q4 2021$45,999,000
-27.0%
2,107,1490.0%0.81%
-7.1%
Q3 2021$62,983,000
-32.5%
2,107,1490.0%0.87%
-41.7%
Q2 2021$93,326,000
-0.2%
2,107,1490.0%1.50%
+6.2%
Q1 2021$93,494,000
-20.2%
2,107,149
-1.4%
1.41%
-13.9%
Q4 2020$117,143,0002,136,0811.64%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,531,800$112,336,00031.61%
RTW INVESTMENTS, LP 15,715,286$697,287,00010.88%
GREAT POINT PARTNERS LLC 760,000$33,721,0006.97%
Copernicus Capital Management, LLC 8,000$355,0005.74%
Ghost Tree Capital, LLC 325,000$14,420,0003.39%
Boxer Capital, LLC 1,466,051$65,049,0002.21%
Perceptive Advisors 2,867,771$127,243,0001.61%
SECTORAL ASSET MANAGEMENT INC 447,885$19,873,0001.51%
RA Capital Management 2,107,149$93,494,0001.41%
Cormorant Asset Management, LP 1,368,550$60,723,0001.35%
View complete list of ROCKET PHARMACEUTICALS INC shareholders